The nature of a-adrenergic receptors in human cerebral arteries was characterized, and alteration of these receptors after subarachnoid hemorrhage was examined using a radioligand binding assay. Norepinephrine content of control arteries was also analyzed and compared with that of arteries after subarachnoid hemorrhage. Norepinephrine content in human cerebral arteries in cases of subarachnoid hemorrhage was about 5% of the control group. Specific binding of [ 
W e have characterized the nature of a-adrenergic receptors in human cerebral arteries and examined the alteration of these receptors after subarachnoid hemorrhage (SAH) using a radioligand binding assay, 1 and we have reported that the Scatchard plot of [ 3 H]yohimbine binding to human cerebral arteries was linear and indicated a single class of binding sites. Recently we examined [ 3 H]yohimbine binding in dog cerebral arteries after superior cervical ganglionectomy, and the results suggested the presence of two different binding sites, with high and low affinity for Oj-adrenergic receptors, that we classify into a 2 H and o^L subtypes, respectively. 2 OjH-Adrenergic receptors are located presynaptically whereas a^L-adrenergic receptors are located postsynaptically. In our previous study 1 on human cerebral arteries, the range of concentrations of [ 3 H]yohimbine used may not have been sufficiently low to detect a small population of the high-affinity binding sites. Therefore, we have now recharacterized a 2 -adrenergic receptors in human cerebral arteries and assayed the content of norepinephrine in arteries after SAH compared with control arteries.
Preliminary findings of the present study were reported at the Twelfth International Symposium on Cerebral Blood Flow and Metabolism, Lund/Ronneby, Sweden, June 1985. 
Subjects and Methods

Collection of Arteries
Cerebral (mainly basilar, circle of Willis, and middle cerebral) arteries were carefully removed from SAH and control patients at autopsy between 1 and 2 hours after death, immediately washed in saline, and placed in a freezer at -80° C. Clinical profiles of the patients are summarized in Table 1 . Arterial membrane homogenates were prepared as described.'
Assay of Norepinephrine Content in Arteries
Norepinephrine content was estimated using highperformance liquid chromatography with an electrochemical detector as previously described. The assay was terminated by addition of 3 ml icecold buffer and rapid filtration through Whatman GF/B glass fiber filters (Clifton, New Jersey) under suction. After washing twice with 3 ml ice-cold buffer, the filters were dried in an oven, transferred to vials, and 8 ml scintillation fluid was added. Radioactivity was counted in a Packard Model 3255 Tri-Carb scintillation spectrometer (Downers Grove, Illinois).
Drugs
[ 3 H]Yohimbine (specific activity 89.7 Ci/mmol) was purchased from New England Nuclear (Boston, Massachusetts), stored at 5° C in ethanol, and protected from light. Immediately before use, appropriate amounts of stock solution were diluted with water so that ethanol concentrations in the final assay system did not exceed 1.0%. All other chemicals were of reagent grade or the purest grade commercially available.
Computer Analysis
Scatchard plots of where B is the total amount of ligand bound at a free ligand concentration S. B raM| and B m x ; are the total number of binding sites (B,^) for two sites having dissociation constants K D| and K,^, respectively. Table 2 shows the norepinephrine content in the cerebral arteries of the control and SAH groups. Norepinephrine content was significantly lower in the arteries from the patients with SAH. 
Results
Norepinephrine Content in Cerebral Arteries
Saturability of Specific
Discussion
Norepinephrine content in human cerebral arteries, despite rather large individual differences, was markedly decreased within a few days of the occurrence of SAH. Previous studies in rabbits 5 and cats 6 showed that experimental SAH induces a transient adrenergic denervation of the cerebral artries. Lobato et al 6 reported that a decrease in norepinephrine content in cat cerebral arteries was detected 3 days after experimental SAH and that the norepinephrine content gradually recovered within 15 days. Our findings confirm that adrenergic denervation occurred within 3 days of SAH in human cerebral arteries.
In our previous paper,' we detected only one class of c^-adrenergic receptors in human cerebral arteries using [ 3 H]yohimbine as a ligand. That previous study may not have fully characterized the receptors because we could not define the location of two types of a 2 -adrenergic receptors; only low-affinity sites were detected. Agrawal and Daniel 7 also reported the existence of one class of c^-adrenergic receptors with low affinity in rat mesenteric arteries. They proposed that the receptors they detected were located postsynaptically since the receptors were not influenced by chemical denervation. More precise analysis of the high- affinity receptor sites enabled us to detect two classes of Oj-adrenergic receptors in human cerebral arteries. Two classes of o^-adrenergic receptors were also detected in dog cerebral arteries. 2 Since high-affinity a,-adrenergic receptors disappeared 7 days after superior cervical ganglionectomy in dog cerebral arteries, it was considered that the high-affinity receptors of human arteries are also located presynaptically and that low-affinity receptors are postsynaptic. Scatchard plots of control human cerebral arteries were similar to those of normal dog cerebral arteries, and Scatchard plots of human cerebral arteries after SAH were similar to those after sympathetic denervation. There were two classes of a 2 -adrenergic receptors in the control human cerebral arteries but only one class of receptors after SAH. Consequently, the absence of high-affinity receptors was considered to represent a dysfunction of presynaptic Oj-adrenergic receptors in the arteries after SAH. As functioning presynaptic a 2 -adrenergic receptors are reported to regulate norepinephrine release, 89 it is possible that SAH induces dysfunction of the regulatory mechanism of norepinephrine release in human cerebral arteries. It was also observed that the affinity of postsynaptic Oj-adrenergic receptors decreased and that B m of these receptors increased in human cerebral arteries after SAH. We found no alteration of the affinity of postsynaptic a 2 -adrenergic receptors in dog cerebral arteries after surgical denervation by superior cervical ganglionectomy 2 though B ,^ of the receptors increased. Therefore, it is considered that SAH not only has a denervation effect on these arteries but also has some direct effect on postsynaptic Oj-adrenergic receptors. The role of postsynaptic a 2 -adrenergic receptors is still controversial. Norepinephrine-induced contraction is weak and mediated by postsynaptic ctjadrenergic receptors in dog cerebral arteries 29 ; in human cerebral arteries, however, norepinephrine-induced contraction is mediated by a,-adrenergic receptors. 10 In such arteries, in which the existence of both a,-and postsynaptic ctj-adrenergic receptors are postulated, the role of postsynaptic a 2 -adrenergic receptors is not clear. Although vasodilatory function of these receptors was also reported," further investigations will be needed to clarify the function of the a 2 -adrenergic receptors and the significance of alterations of such receptors after SAH.
In conclusion, sympathetic denervation of the cerebral arteries and subsequent dysfunction of presynaptic Oj-adrenergic receptors were observed in human cerebral arteries after SAH. Dysfunction of the regulatory mechanism of norepinephrine release may be related to the occurrence of delayed vasospasm after SAH.
